In a further step in South Korea-based Celltrion’s ambitions to diversify from its core biosimilars focus, the company has ...

German pharma major Boehringer Ingelheim has broadened its collaboration with Swiss biotech CDR-Life through a global ...

Italy based clinical-stage biotech AAVantgarde Bio today announced the successful closing of a $141 million (122 million ...

US pharma giant Merck & Co, known as MSD outside of the USA and Canada, today announced that the company, through subsidiary ...

US biopharma Vertex Pharmaceuticals has reported consolidated financial results for the third quarter of 2025 and refined its ...

Swiss specialty drugmaker Santhera Pharmaceuticals saw its shares rise 5.8% to 10.90 francs today, after it reported positive ...

The US Food and Drug Administration (FDA) has approved Belgium drugmaker UCB’s Kygevvi (doxecitine and doxribtimine) powder ...

US pharma major Eli Lilly has revealed plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, ...

Sickle cell disease (SCD) is a group of inherited blood disorders characterised by a single point mutation in the β-globin ...

The bidding war for US obesity focused biotech Metsera, which has attracted offers from Pfizer and Novo Nordisk , and resulted in lawsuits by the US giant taking legal action against the Danish firm ...

US pharma giant Pfizer (NYSE: PFE) reported financial results for the third quarter of 2025 on Tuesday. Revenues for the quarter were 7% lower than they were for the same quarter a year ago, at $16.65 ...

SOTIO Biotech, a Czech clinical-stage biopharma owned by PPF Group, today announced the promotion of Dr Vivi Boura, an ...